A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Virginia
Stanford University
Memorial Sloan Kettering Cancer Center
Zhejiang University
University of Florida
SCRI Development Innovations, LLC
Abramson Cancer Center at Penn Medicine
Cambridge University Hospitals NHS Foundation Trust
Swiss Cancer Institute
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
Roswell Park Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
University of Southern California
Fox Chase Cancer Center
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Dartmouth-Hitchcock Medical Center
Duke University
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Cancer Research UK
University of Michigan Rogel Cancer Center
University of Utah